Erythropoietin is not only for patients with renal diseases--new indications in sight
Hast, R.; Stenke, L.
Lakartidningen 89(13): 1044-1045
1992
ISSN/ISBN: 0023-7205 PMID: 1552801 Document Number: 396584
Document emailed within 1 workday
Related Documents
Dimitrakov, D.; Kumchev, E.; Tllkian, E. 1994: Study of the effect of recombinant erythropoietin on renal anaemia in predialysis patients with chronic renal failure Folia Medica 36(3): 31-36Dreiskämper, K. 1987: Imaging diagnosis of renal diseases based on indications Schweizerische Rundschau für Medizin Praxis 76(4): 76-85
Essers, U.; Müller, W.; Heintz, R. 1975: Effect of erythropoietin in normal men and in patients with renal insufficiency Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 11: 398-402
Laurent, J.; Gilson-Henry, P.; Lagrue, G. 1986: Desensitization of allergic diseases. Renal contra-indications should not be forgotten Presse Medicale 15(9): 442
Hu, J.P.; Cheng, X.; Xu, X.F.; Yu, G.J.; Luo, F.; Zhang, G.S.; Yang, N.; Shen, P.; Yan, X.Y. 2016: Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia Journal of Biological Regulators and Homeostatic Agents 30(2): 535-540
Tapolyai, M.; Schede Don, K.; Gupta, B. 1999: Rhu-erythropoietin treatment of pre-ESRD patients slows the rate of progression of renal decline Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 91A
Cao, W.; Liu, J.-H.; Zhang, H.; Zhang, L.; Zhang, L.-Y.; Pan, M.-M. 2010: Effect of acupoint injection on erythropoietin resistance in patients with chronic renal failure Zhongguo Zhen Jiu 30(11): 891-895
Boratyńska, M.; Szewczyk, Z.; Nowakowska, B.; Baldy-Chudzik, K.; Pytel, A. 1995: Effect of recombinant human erythropoietin on kinetics of alloantibodies in patients awaiting renal allograft Przeglad Lekarski 52(9): 424-427
Thitiarchakul, S.; Tasanarong, A. 2007: 12-week clinical effects of erythropoietin espogen in end stage renal patients undergoing hemodialysis Journal of the Medical Association of Thailand 90(4): 636-642
Suzuki, H.; Murakami, M.; Ichihara, A.; Saruta, T. 1992: Alterations in sex hormones and sexual function of patients with renal failure treated with recombinant human erythropoietin Nihon Jinzo Gakkai Shi 34(1): 79-84
Zelichowski, G.; Lubas, A.; Sienkiewicz, M.; Janusz, E.; Wańkowicz, Z. 2008: Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 312-315
Ohkubo, M.; Ishimitsu, T.; Kawaguchi, T.; Abe, M.; Yagi, S. 1993: Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia Nihon Jinzo Gakkai Shi 35(2): 171-177
Dimitrakov, D.; Kunchev, E. 1992: Application of recombinant human erythropoietin in patients with polycystic kidney disease and chronic renal failure Folia Medica 34(1): 41-44
Yamazaki, C.; Watanabe, Y.; Sakamoto, N. 1993: Pharmacokinetic study of recombinant human erythropoietin treatment in pre-dialysis end stage renal disease patients Nihon Jinzo Gakkai Shi 35(11): 1233-1242
Kokot, F.; Franek, E.; Kokot, M.; Wiecek, A.; Kozielski, J.; Rauer, R.; Oklek, K. 1994: Erythropoietin secretion in patients with chronic obstructive lung diseases during normobaric oxygen inhalation Casopis Lekaru Ceskych 133(11): 334-337
Burak, W.; Grzeszczak, W.; Trelewicz, P.; Zukowska-Szczechowska, E. 1996: The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin Przeglad Lekarski 53(2): 54-57
Wiecek, A.; Kokot, F.; Spiechowicz, U.; Cieplok, J.; Czerwieńska, B.; Strzelczyk, P.; Dyjas, R. 1996: Requirement for blood in hemodialyzed patients with chronic renal failure in the period before and after introduction to erythropoietin (r-HuEPO) treatment Przeglad Lekarski 53(12): 866-869
Ksiazek, A.; Baranowska-Daca, E. 1993: Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S550-S552
Jeffrey, R.F.; Kendall, R.G.; Prabhu, P.; Norfolk, D.R.; Will, E.J.; Davison, A.M. 1995: Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation Clinical Nephrology 44(4): 241-247
Bergman, P.; Gudmundsson, G.H.; Agerberth, B. 2008: Natural immunity--first line defense. new treatment against infections and autoimmune diseases in sight Lakartidningen 105(34): 2254-2259